Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2080062623;62624;62625 chr2:178589327;178589326;178589325chr2:179454054;179454053;179454052
N2AB1915957700;57701;57702 chr2:178589327;178589326;178589325chr2:179454054;179454053;179454052
N2A1823254919;54920;54921 chr2:178589327;178589326;178589325chr2:179454054;179454053;179454052
N2B1173535428;35429;35430 chr2:178589327;178589326;178589325chr2:179454054;179454053;179454052
Novex-11186035803;35804;35805 chr2:178589327;178589326;178589325chr2:179454054;179454053;179454052
Novex-21192736004;36005;36006 chr2:178589327;178589326;178589325chr2:179454054;179454053;179454052
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Ig-122
  • Domain position: 32
  • Structural Position: 45
  • Q(SASA): 0.6624
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/G rs1404277332 -0.449 0.822 N 0.608 0.337 0.465294738428 gnomAD-2.1.1 4.03E-06 None None None None I None 0 0 None 0 5.58E-05 None 0 None 0 0 0
E/G rs1404277332 -0.449 0.822 N 0.608 0.337 0.465294738428 gnomAD-4.0.0 1.59335E-06 None None None None I None 0 0 None 0 2.7767E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.144 likely_benign 0.1303 benign -0.134 Destabilizing 0.822 D 0.595 neutral N 0.508625246 None None I
E/C 0.8324 likely_pathogenic 0.8465 pathogenic -0.093 Destabilizing 0.998 D 0.741 deleterious None None None None I
E/D 0.115 likely_benign 0.1236 benign -0.323 Destabilizing 0.014 N 0.311 neutral N 0.488441975 None None I
E/F 0.7625 likely_pathogenic 0.7425 pathogenic -0.063 Destabilizing 0.993 D 0.725 prob.delet. None None None None I
E/G 0.2712 likely_benign 0.2416 benign -0.307 Destabilizing 0.822 D 0.608 neutral N 0.499623664 None None I
E/H 0.4534 ambiguous 0.4286 ambiguous 0.345 Stabilizing 0.998 D 0.61 neutral None None None None I
E/I 0.2786 likely_benign 0.2663 benign 0.276 Stabilizing 0.956 D 0.733 prob.delet. None None None None I
E/K 0.1859 likely_benign 0.158 benign 0.418 Stabilizing 0.822 D 0.571 neutral N 0.475800752 None None I
E/L 0.3419 ambiguous 0.3242 benign 0.276 Stabilizing 0.956 D 0.659 neutral None None None None I
E/M 0.4271 ambiguous 0.4052 ambiguous 0.15 Stabilizing 0.998 D 0.701 prob.neutral None None None None I
E/N 0.2119 likely_benign 0.2093 benign 0.107 Stabilizing 0.915 D 0.6 neutral None None None None I
E/P 0.9087 likely_pathogenic 0.9022 pathogenic 0.159 Stabilizing 0.978 D 0.676 prob.neutral None None None None I
E/Q 0.1414 likely_benign 0.1286 benign 0.139 Stabilizing 0.942 D 0.604 neutral N 0.472741804 None None I
E/R 0.3394 likely_benign 0.2877 benign 0.66 Stabilizing 0.978 D 0.616 neutral None None None None I
E/S 0.1773 likely_benign 0.1675 benign -0.034 Destabilizing 0.754 D 0.553 neutral None None None None I
E/T 0.1547 likely_benign 0.1417 benign 0.109 Stabilizing 0.16 N 0.383 neutral None None None None I
E/V 0.1563 likely_benign 0.1472 benign 0.159 Stabilizing 0.942 D 0.605 neutral N 0.50978004 None None I
E/W 0.9338 likely_pathogenic 0.9272 pathogenic 0.036 Stabilizing 0.998 D 0.722 prob.delet. None None None None I
E/Y 0.6644 likely_pathogenic 0.6526 pathogenic 0.175 Stabilizing 0.993 D 0.723 prob.delet. None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.